Alpha 2.0
Login Register
» Articles » PMID: 4172047

Treatment of Carcinoma of the Head and Neck with Intravenous Methotrexate

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 1968 May 1
PMID 4172047
Citations 7
Authors
L A Leone
M M ALBALA
V B Rege
Affiliations
Soon will be listed here.
Citing Articles

Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers.

Kozminski P, Halik P, Chesori R, Gniazdowska E Int J Mol Sci. 2020; 21(10).

PMID: 32423175 PMC: 7279024. DOI: 10.3390/ijms21103483.

Head and neck cancer: guidelines for chemotherapy.

Catimel G Drugs. 1996; 51(1):73-88.

PMID: 8741233 DOI: 10.2165/00003495-199651010-00006.

Methotrexate in the treatment of malignant tumours: evidence for the possible participation of host defence mechanisms.

Stewart T, Klassen D, Crook A Can Med Assoc J. 1969; 101(4):191-9.

PMID: 5811699 PMC: 1946105.

Results in fifty cases of advanced squamous cell carcinoma of the head and neck treated by intravenous chemotherapy.

Priestman T Br J Cancer. 1973; 27(5):400-5.

PMID: 4713171 PMC: 2008800. DOI: 10.1038/bjc.1973.48.

Intra-arterial infusion with methotrexate in the rat.

Sindram P, Snow G, van Putten L Br J Cancer. 1974; 30(4):349-54.

PMID: 4548653 PMC: 2009300. DOI: 10.1038/bjc.1974.204.